Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5700-0.0075 (-1.30%)
At close: 12:30PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts2221
Avg. Estimate-0.17-0.17-0.71-0.6
Low estimate-0.19-0.19-0.76-0.6
High estimate-0.15-0.16-0.66-0.6
Year ago EPS-0.19-0.23-0.83-0.71
Revenue estimateCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
No. of analysts2221
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/09/202230/12/202230/03/202329/06/2023
Est. EPS-0.22-0.2-0.22-0.18
Actual EPS-0.19-0.23-0.19-0.16
Difference0.03-0.030.030.02
Surprise %13.60%-15.00%13.60%11.10%
EPS trendCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Current estimate-0.17-0.17-0.71-0.6
7 days ago-0.17-0.17-0.71-0.6
30 days ago-0.17-0.17-0.71-0.6
60 days ago-0.15-0.14-0.63-0.45
90 days ago-0.15-0.14-0.63-0.45
EPS revisionsCurrent qtr. (Sep 2023)Next qtr. (Dec 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMNPRIndustrySector(s)S&P 500
Current qtr.10.50%N/AN/AN/A
Next qtr.26.10%N/AN/AN/A
Current year14.50%N/AN/AN/A
Next year15.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A